181 related articles for article (PubMed ID: 31849155)
1. Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary intervention.
Wang W; Zhang X; Chen K; Yin L; Gong M; Liu Y; Tse G; Wu L; Li G; Liu T
Ann Noninvasive Electrocardiol; 2020 Jul; 25(4):e12736. PubMed ID: 31849155
[TBL] [Abstract][Full Text] [Related]
2. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: A triple-blind, randomized, placebo-controlled study.
Suleimani HF; Eshraghi A; Daloee MH; Hoseini S; Nakhaee N
Electron Physician; 2017 Aug; 9(8):4934-4941. PubMed ID: 28979725
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
[TBL] [Abstract][Full Text] [Related]
5. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
[TBL] [Abstract][Full Text] [Related]
6. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
[TBL] [Abstract][Full Text] [Related]
8. Continuous administration of nicorandil decreases QT dispersion during the chronic phase of acute myocardial infarction.
Akagi T; Sarazawa K; Inai Y; Kitagawa M; Takahashi N; Hamanaka I; Yamazaki T; Takebe M; Hama N; Hiraoka Y; Ueda K; Nakazawa K; Matsumoto N
Int Heart J; 2006 May; 47(3):351-61. PubMed ID: 16823241
[TBL] [Abstract][Full Text] [Related]
9. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
10. [Effect of nicorandil on ventricular arrhythmia in patients with acute ST-segment elevation myocardial infarction underwent emergent percutaneous coronary intervention treatment].
Wang YP; Zhang Y; Sun YR; Sun ZG; Zuo ZK; Feng ZR; Chang FY; Xu YC; Chen BZ; Ye YY
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):701-705. PubMed ID: 28851188
[No Abstract] [Full Text] [Related]
11. Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina.
Kim JH; Jeong MH; Yun KH; Kim KH; Kang DK; Hong SN; Lim SY; Lee SH; Lee YS; Hong YJ; Park HW; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
Circ J; 2005 Mar; 69(3):306-10. PubMed ID: 15731536
[TBL] [Abstract][Full Text] [Related]
12. Manual Thrombus Aspiration and the Improved Survival of Patients With Unstable Angina Pectoris Treated With Percutaneous Coronary Intervention (30 Months Follow-Up).
Yildiz BS; Bilgin M; Zungur M; Alihanoglu YI; Kilic ID; Buber I; Ergin A; Kaftan HA; Evrengul H
Medicine (Baltimore); 2016 Feb; 95(8):e2919. PubMed ID: 26937936
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
[TBL] [Abstract][Full Text] [Related]
14. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic measures of ventricular repolarization dispersion and arrhythmic outcomes among ST elevation myocardial infarction patients with pre-infarction angina undergoing primary percutaneous coronary intervention.
Ahmed TAN; Abdel-Nazeer AA; Hassan AKM; Hasan-Ali H; Youssef AA
Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12637. PubMed ID: 30737993
[TBL] [Abstract][Full Text] [Related]
16. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
[TBL] [Abstract][Full Text] [Related]
18. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
[TBL] [Abstract][Full Text] [Related]
19. Coronary microvascular response to intracoronary administration of nicorandil.
Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
Kato K
Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
